Nonalcoholic Steatohepatitis (NASH): Epidemiology Forecasting Intelligence
![](/report_cover/11052/nonalcoholic-steatohepatitis-nash-epidemiology-forecasting-intelligence_en.gif)
CmaxInsight’s “Nonalcoholic Steatohepatitis (NASH)-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Nonalcoholic Steatohepatitis (NASH) epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.
Our epidemiology services include:
Our epidemiology services include:
- Incidence and prevalence
- Diagnosis rate, treatment rate and mortality patterns
- Epidemiology-based forecasting and disease trends
- Size of different patient segments in a disease area
- Population based: disease occurrence, co-morbidities and treatment patterns
- Geographic - Regional - Ethnic differences
- Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
- Patient treatment journey
- Treatment algorithm and guidelines
- Assesses the disease risk and burden
- Highlights the unmet needs
- Market driver and barrier
- Growth opportunities and market trend analysis
- This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
- To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
- All of the sources used to generate the data and analysis have been identified in the report.
1. REPORT INTRODUCTION
2. NONALCOHOLIC STEATOHEPATITIS (NASH) EPIDEMIOLOGY OVERVIEW AT A GLANCE
3. MARKET SHARE DISTRIBUTION OF NONALCOHOLIC STEATOHEPATITIS (NASH)
4. DISEASE BACKGROUND AND OVERVIEW: NONALCOHOLIC STEATOHEPATITIS (NASH)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. NONALCOHOLIC STEATOHEPATITIS (NASH) EPIDEMIOLOGY
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. EPIDEMIOLOGY OF NONALCOHOLIC STEATOHEPATITIS (NASH) BY COUNTRIES
7. UNITED STATES
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
7.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
7.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
7.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
7.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.1.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.1.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.1.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.1.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.2.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.2.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.2.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.2.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.3.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.3.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.3.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.3.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.4.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.4.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.4.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.4.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.5.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.5.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.5.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.5.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
9. JAPAN
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
9.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
9.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
9.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
9.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
10. UNMET NEEDS
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.
2. NONALCOHOLIC STEATOHEPATITIS (NASH) EPIDEMIOLOGY OVERVIEW AT A GLANCE
3. MARKET SHARE DISTRIBUTION OF NONALCOHOLIC STEATOHEPATITIS (NASH)
4. DISEASE BACKGROUND AND OVERVIEW: NONALCOHOLIC STEATOHEPATITIS (NASH)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. NONALCOHOLIC STEATOHEPATITIS (NASH) EPIDEMIOLOGY
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. EPIDEMIOLOGY OF NONALCOHOLIC STEATOHEPATITIS (NASH) BY COUNTRIES
7. UNITED STATES
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
7.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
7.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
7.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
7.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.1.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.1.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.1.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.1.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.2.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.2.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.2.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.2.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.3.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.3.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.3.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.3.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.4.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.4.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.4.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.4.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
8.5.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
8.5.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
8.5.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
8.5.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
9. JAPAN
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Nonalcoholic Steatohepatitis (NASH)
9.3. Sub-Type Specific cases of Nonalcoholic Steatohepatitis (NASH)*
9.4. Sex- Specific Cases of Nonalcoholic Steatohepatitis (NASH)*
9.5. Diagnosed Cases of Nonalcoholic Steatohepatitis (NASH)
9.6. Treated Cases of Nonalcoholic Steatohepatitis (NASH)
10. UNMET NEEDS
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.
LIST OF TABLES
Table 1: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM
Table 2: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Table 4: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Table 5: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Table 6: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Table 7: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Table 8: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Table 9: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Table 10: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Table 11: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Table 12: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Table 13: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Table 14: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Table 15: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Table 16: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Table 17: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Table 18: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Table 19: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Table 20: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Table 21: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Table 22: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Table 23: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Table 24: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Table 25: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Table 26: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Table 27: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Table 28: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Table 29: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Table 30: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Table 31: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Table 32: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Table 33: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Table 34: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Table 35: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Table 36: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Table 37: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM
Table 2: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Table 4: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Table 5: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Table 6: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Table 7: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Table 8: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Table 9: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Table 10: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Table 11: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Table 12: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Table 13: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Table 14: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Table 15: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Table 16: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Table 17: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Table 18: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Table 19: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Table 20: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Table 21: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Table 22: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Table 23: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Table 24: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Table 25: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Table 26: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Table 27: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Table 28: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Table 29: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Table 30: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Table 31: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Table 32: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Table 33: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Table 34: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Table 35: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Table 36: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Table 37: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
*Indication Specific
LIST OF FIGURES
Figure 1: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Figure 4: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Figure 5: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Figure 6: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Figure 7: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Figure 8: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Figure 9: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Figure 10: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Figure 11: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Figure 12: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Figure 13: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Figure 14: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Figure 15: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Figure 16: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Figure 17: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in United France
Figure 18: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Figure 19: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Figure 20: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Figure 21: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Figure 22: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Figure 23: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Figure 24: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Figure 25: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Figure 26: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Figure 27: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Figure 28: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Figure 29: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Figure 30: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Figure 31: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Figure 32: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Figure 33: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Figure 34: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Figure 35: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Figure 36: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Figure 37: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
*Indication Specific
Figure 1: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Figure 4: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Figure 5: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in United States*
Figure 6: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Figure 7: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in United States
Figure 8: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Figure 9: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Figure 10: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany*
Figure 11: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Figure 12: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Germany
Figure 13: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Figure 14: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Figure 15: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in France*
Figure 16: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in France
Figure 17: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in United France
Figure 18: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Figure 19: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Figure 20: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy*
Figure 21: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Figure 22: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Italy
Figure 23: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Figure 24: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Figure 25: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain*
Figure 26: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Figure 27: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Spain
Figure 28: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Figure 29: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Figure 30: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in UK*
Figure 31: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Figure 32: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in UK
Figure 33: Prevalent/Incident Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Figure 34: Sub-Type Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Figure 35: Sex- Specific Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan*
Figure 36: Diagnosed Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
Figure 37: Treated Cases of the Nonalcoholic Steatohepatitis (NASH) in Japan
*Indication Specific